Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreYour selected location is
Middle East / Africa
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD31 expression on human peripheral blood monocytes and granulocytes. Whole blood was stained with either PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; dashed line histogram) or PE-Cy™7 Mouse Anti-Human CD31 antibody (Cat. No. 563651; solid line histogram). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes (Left Panel) or granulocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD31 expression on human peripheral blood monocytes and granulocytes. Whole blood was stained with either PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; dashed line histogram) or PE-Cy™7 Mouse Anti-Human CD31 antibody (Cat. No. 563651; solid line histogram). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes (Left Panel) or granulocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD31 expression on human peripheral blood monocytes and granulocytes. Whole blood was stained with either PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; dashed line histogram) or PE-Cy™7 Mouse Anti-Human CD31 antibody (Cat. No. 563651; solid line histogram). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes (Left Panel) or granulocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD31 expression on human peripheral blood monocytes and granulocytes. Whole blood was stained with either PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; dashed line histogram) or PE-Cy™7 Mouse Anti-Human CD31 antibody (Cat. No. 563651; solid line histogram). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes (Left Panel) or granulocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD31 expression on human peripheral blood monocytes and granulocytes. Whole blood was stained with either PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; dashed line histogram) or PE-Cy™7 Mouse Anti-Human CD31 antibody (Cat. No. 563651; solid line histogram). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes (Left Panel) or granulocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD31 expression on human peripheral blood monocytes and granulocytes. Whole blood was stained with either PE-Cy™7 Mouse IgG1, κ Isotype Control (Cat. No. 557872; dashed line histogram) or PE-Cy™7 Mouse Anti-Human CD31 antibody (Cat. No. 563651; solid line histogram). The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of intact monocytes (Left Panel) or granulocytes (Right Panel). Flow cytometric analysis was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The WM59 monoclonal antibody specifically binds to platelet endothelial cell adhesion molecule-1, (PECAM-1, PECAM1), which is also known as GPIIA', or EndoCAM. CD31 is a 130 kDa type I transmembrane glycoprotein that belongs to the Ig gene superfamily. CD31 has wide tissue distribution and is expressed on platelets, monocytes, granulocytes, NK cells, T cell subsets, and in high amounts on endothelial cells. CD31 functions as a vascular endothelial cell adhesion molecule and is involved in the transendothelial migration of leucocytes in inflammatory responses. It might be involved in thrombosis, angiogenesis, and wound healing. The WM59 appears to recognize an epitope proximal to extracellular domain 2 of CD31.
Clone WM59 also cross-reacts with peripheral blood platelets and leukocytes of baboon, and both rhesus and cynomolgus macaque monkeys. The staining intensity of WM59+ platelets is similiar to that observed with peripheral blood platelets from normal human donors. Lymphocytes, monocytes, and granulocytes react less with WM59 than normal human leukocytes.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.